Management of disseminated intravascular coagulopathy with direct factor Xa inhibitor rivaroxaban in Klippel–Trénaunay syndrome

التفاصيل البيبلوغرافية
العنوان: Management of disseminated intravascular coagulopathy with direct factor Xa inhibitor rivaroxaban in Klippel–Trénaunay syndrome
المؤلفون: Hans-Ulrich Haering, Bernd Balletshofer, Kilian Rittig, Lothar Kanz, Elko Randrianarisoa, Hans-Georg Kopp, Jaschonek K
المصدر: Blood Coagulation & Fibrinolysis. 24:766-770
بيانات النشر: Ovid Technologies (Wolters Kluwer Health), 2013.
سنة النشر: 2013
مصطلحات موضوعية: Male, Klippel-Trenaunay-Weber Syndrome, medicine.medical_specialty, Klippel-Trenaunay syndrome, Adolescent, medicine.drug_mechanism_of_action, medicine.drug_class, Morpholines, Factor Xa Inhibitor, Thiophenes, Recurrent deep vein thrombosis, Rivaroxaban, Consumptive Coagulopathy, Coagulopathy, medicine, Humans, business.industry, Anticoagulant, Anticoagulants, Soft tissue, Hematology, General Medicine, Disseminated Intravascular Coagulation, medicine.disease, Surgery, Factor Xa, business, medicine.drug
الوصف: Klippel-Trénaunay syndrome (KTS) is a rare congenital anomaly characterized by malformation of lymph and blood vessels as well as growth disturbance of soft tissue and bone. The clinical picture is variable and associated with an increased risk of thromboembolic events mediated by intravascular coagulopathy in venous malformations. Here, we report on a male patient with KTS suffering from recurrent deep vein thrombosis (DVT) and life-threatening bleeding due to consumptive coagulopathy. Furthermore, we describe the successful long-term anticoagulant management with rivaroxaban.
تدمد: 0957-5235
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5d41ce444997182254f22b61d65687Test
https://doi.org/10.1097/mbc.0b013e3283626238Test
رقم الانضمام: edsair.doi.dedup.....9a5d41ce444997182254f22b61d65687
قاعدة البيانات: OpenAIRE